Skip to main content

Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders

Financial updates

Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces that at its Annual General Meeting of Shareholders (AGM) held today, the proposal for a specific authorization for the issuance of shares (or rights to acquire shares) to finance mergers, acquisitions, or strategic alliances, was not put up for a vote. All other proposals were approved.

Read more


  • Cookies: This website uses cookies Check the cookies page for more information Accept Decline